We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

TxCell Enters Col-Treg into Full Development for the Rare Disease Autoimmune Uveitis

News   Jan 08, 2014

 
TxCell Enters Col-Treg into Full Development for the Rare Disease Autoimmune Uveitis
 
 
 

RELATED ARTICLES

Dementia Associated With Altered Immune System

News

Recent research has revealed increased inflammatory activity in some patients with frontotemporal dementia.

READ MORE

Developing Pioneering Cell Therapies for Immunotherapy Non-responders

News

New research signposts a novel, less invasive method to identify killer T lymphocytes in patients with gastrointestinal tumors with low mutational burden who are refractory to currently-approved immune-based treatments.

READ MORE

"Exhausted" T Cells Lose the Battle Against Disease

News

A new study has identified the molecular mechanisms behind which T cells will lose the battle against cancer earlier, which could inform treatment.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE